Vorasidenib Patent Expiration
Vorasidenib was first introduced by Servier Pharmaceuticals Llc
Vorasidenib Patents
Given below is the list of patents protecting Vorasidenib, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Voranigo | US11345677 | Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same | Jan 16, 2039 | Servier |
| Voranigo | US11844758 | Therapeutically active compounds and their methods of use | Dec 04, 2035 | Servier |
| Voranigo | US10172864 | Therapeutically active compounds and their methods of use | Jul 11, 2034 | Servier |
| Voranigo | US9579324 | Therapeutically active compounds and their methods of use | Jul 11, 2034 | Servier |
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List